Purified anti-β-Catenin non-phospho (active) (S33/S37/T41),BioLegend,631851
This antibody (clone W22009A) cross-reacts with mouse and rat non-phospho β-catenin (active) in western blot (WB).For immunocytochemistry (ICC), 4% PFA fixation followed by permeabilization with 0.5% Triton X-100 or ice-cold methanol or fixation with ice-cold methanol is recommended.For Immunohistochemistry - Paraffin (IHC-P), Citrate Buffer (Cat. No. 420901) or Tris-EDTA pH 9.0 is recommended for antigen retrieval.
Host
Rat
Reactivity
Human, Mouse, Rat
Application
WB - Quality testedICC, IHC-P - Verified
Platform ID
BAB086525328

BioLegend
Contact
Tel: 1-858-455-9588
Fax: +49 (4131) 7023913
Email:
Specifications
Scientific Background
β-catenin is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. β-catenin also plays a key role in Wnt signaling pathways and thus is involved in neural differentiation, synaptic plasticity, neurodegenerative disease, and prevention of apoptosis. GSK-3β destabilizes β-catenin by phosphorylating it at Ser33, Ser37, and Thr41. Mutations at these sites lead to stabilization of β-catenin protein levels and have been found in many tumor cell lines. This protein binds to the product of the adenomatous polyposis coli (APC) gene, which is mutated in the adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer.
Category Paths
- Products>Primary Antibodies>IHC Antibodies
Please provide the required information below so that we can quickly source your products.
